360Dx: Owlstone Medical, Actelion Pharmaceuticals Partner to Develop Pulmonary Hypertension Breath Test
Published on: 22 May 2019, under Breath Biopsy
Owlstone Medical’s strategic collaboration with Actelion Pharmaceuticals Ltd., one of The Janssen Pharmaceutical Companies of Johnson & Johnson, to discover and validate a breath-based test to aid early diagnosis of pulmonary hypertension, has been featured in an article by 360Dx.
Owlstone Medical, Actelion Pharmaceuticals Partner to Develop Pulmonary Hypertension Breath Test
Click here to read the article on 360Dx:
Breath Biopsy®
If you want to learn more about how Owlstone Medical’s Breath Sampling and Analysis technology and Services are being utilized in early detection and precision medicine, why not download our free ebook: Breath Biopsy: The Complete Guide?
